Literature DB >> 22479220

The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2.

David B Nash, Michael Toscani, F Randy Vogenberg.   

Abstract

Part 2 of BFAC's survey reveals a range of understanding among providers, purchasers, and payers about the management of biologics and the implications of their use.

Year:  2011        PMID： 22479220      PMCID： PMC3278121     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  1 in total

1.  The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders.

Authors:  David B Nash; Michael Toscani; F Randy Vogenberg
Journal:  Biotechnol Healthc       Date:  2011
  1 in total
  1 in total

1.  Beyond the cost of biologics: employer survey reveals gap in understanding role of specialty pharmacy and benefit design.

Authors:  F Randy Vogenberg; Cheryl Larson; Margaret Rehayem; Larry Boress
Journal:  Am Health Drug Benefits       Date:  2012-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.